Headlands Research, a leading multinational network of clinical trial sites, has announced the acquisition of an established clinical research site, now known as Headlands Research Eastern Massachusetts. The site has specialized in neurodegenerative diseases such as Alzheimer’s disease and Parkinson’s disease for over 25 years. “With its longstanding focus on memory and movement disorders, Headlands Research Eastern Massachusetts strengthens the breadth and depth of our existing neurology specialty research,” said Cathy Collins, CEO of Headlands Research. “We are proud to welcome Headlands Research Eastern Massachusetts to our expanding network of clinical trial sites, helping to make clinical trials — and the innovative therapies they provide — accessible to more people.”
Read the full article: Headlands Research Acquires Established Eastern Massachusetts–Based Research Site Specializing in Neurodegenerative Diseases //
Source: https://www.businesswire.com/news/home/20230418005273/en/Headlands-Research-Acquires-Established-Eastern-Massachusetts%E2%80%93Based-Research-Site-Specializing-in-Neurodegenerative-Diseases